Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesComparing Three Software Tools for Implementing Markov Models for Health Economic Evaluations
PharmacoEconomics, 09/18/09
Menn P et al. – Excel offers an intuitive spreadsheet interface, but the acquisition of and the training in TreeAge or Arena is worthwhile for more complex models. Double implementation is a practicable validation technique that should be conducted to ensure correct model implementation.
Related Articles
Economic Evaluation and Cost-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation
PharmacoEconomics, 10/07/09
Relevance Score: 67%
30 Years of Pharmaceutical Cost-Utility Analyses: Growth, Diversity and Methodological Improvement
PharmacoEconomics, 10/13/09
Relevance Score: 66%
Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings
Health Policy and Planning, 10/21/09
Relevance Score: 65%
Financial Risk of the Biotech Industry versus the Pharmaceutical Industry
Applied Health Economics and Health Policy, 10/20/09
Relevance Score: 64%
Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese Perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide
PharmacoEconomics, 10/13/09
Relevance Score: 64%
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Early and Late Direct Costs in a Southern African Antiretroviral Treatment Programme: A Retrospective Cohort Analysis
PLoS Medicine, 12/04/09
Economic Evaluation of Pharmacotherapy of Migraine Pain: A Review of the Literature
Journal Of Pain & Palliative Care Pharmacotherapy, 12/02/09
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Infection Control and Hospital Epidemiology, 12/02/09
Sponsor
Article Search
Sponsor